Cargando…
Matrix metalloproteinase-9 predicts pulmonary status declines in α(1)-antitrypsin deficiency
BACKGROUND: Matrix metalloproteinase-9 (MMP-9) may be important in the progression of emphysema, but there have been few longitudinal clinical studies of MMP-9 including pulmonary status and COPD exacerbation outcomes. METHODS: We utilized data from the placebo arm (n = 126) of a clinical trial of p...
Autores principales: | Omachi, Theodore A, Eisner, Mark D, Rames, Alexis, Markovtsova, Lada, Blanc, Paul D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073899/ https://www.ncbi.nlm.nih.gov/pubmed/21429222 http://dx.doi.org/10.1186/1465-9921-12-35 |
Ejemplares similares
-
Health status decline in α-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies?
por: Stockley, Robert A., et al.
Publicado: (2018) -
Update on α(1)-antitrypsin deficiency
por: Ferrarotti, Ilaria, et al.
Publicado: (2018) -
Alpha-1-antitrypsin deficient man presenting with lung function decline associated with dust exposure: a case report
por: Zutler, Moshe, et al.
Publicado: (2011) -
Unexpected timely fracture union in matrix metalloproteinase 9 deficient mice
por: Yuasa, Masato, et al.
Publicado: (2018) -
Appropriateness of Newborn Screening for α1-Antitrypsin Deficiency
por: Teckman, Jeffrey, et al.
Publicado: (2014)